Showing results (81-90 of 254) with videos related to
Sort By:
Pageof 26
Scandinavian Journal of Gastroenterology|June 15, 2007
Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseasesRinse K Weersma, Liekele E Oostenbrug, Ilja M Nolte, et al.Trends in Molecular Medicine|August 9, 2023
The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel diseaseSem Geertsema, Arno R Bourgonje, Raphael R Fagundes, et al.Scientific Reports|December 16, 2015
A simple coculture system shows mutualism between anaerobic faecalibacteria and epithelial Caco-2 cellsMehdi Sadaghian Sadabad, Julius Z H von Martels, Muhammed Tanweer Khan, et al.Nutrition (Burbank, Los Angeles County, Calif.)|March 1, 2017
High prevalence of cachexia in newly diagnosed head and neck cancer patients: An exploratory studyHarriët Jager-Wittenaar, Pieter U Dijkstra, Gerard Dijkstra, et al.Iscience|July 24, 2026
Systemic antibody responses against bacterial and viral antigens associate with fatigue in patients with inflammatory bowel diseaseMaximilian G Griesbaum, Thomas Vogl, Marijn C Visschedijk, et al.Gut|September 26, 2014
The ATG16L1-T300A allele impairs clearance of pathosymbionts in the inflamed ileal mucosa of Crohn's disease patientsMehdi Sadaghian Sadabad, Anouk Regeling, Marcus C de Goffau, et al.Inflammatory Bowel Diseases|September 20, 2007
Early bacterial dependent induction of inducible nitric oxide synthase (iNOS) in epithelial cells upon transfer of CD45RB(high) CD4(+) T cells in a model for experimental colitisGerard Dijkstra, Saravanan Yuvaraj, Han-Qing Jiang, et al.Pharmaceutical Research|March 17, 2012
A non-invasive, low-cost study design to determine the release profile of colon drug delivery systems: a feasibility studyMarina J M Maurer, Reinout C A Schellekens, Klaus D Wutzke, et al.Plos One|September 17, 2021
Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFα therapy in inflammatory bowel diseaseNaomi Karmi, Amber Bangma, Lieke M Spekhorst, et al.Alimentary Pharmacology & Therapeutics|April 28, 2020
A comparative analysis of tioguanine versus low-dose thiopurines combined with allopurinol in inflammatory bowel disease patientsVince B C Biemans, Edo Savelkoul, Ruben Y Gabriëls, et al.Pageof 26